Publication | Closed Access

Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial

OncologyMedicineMetronomic TherapyDouble-blind TrialBronchial NeoplasmCancer TreatmentPharmacologyRadiation OncologyLung Cancer